Cerebral Perfusion in a Patient with Dengue Hemorrhagic Fever

Nitamar Abdala, MD, Radiology Professor, and Carolina Salazar, MD, Radiology Resident
UMDI – Unidade Mogiana de Diagóstico por Imagem, São Paulo, Brazil

 |  2006-11-06

History

A 53 year old male patient with acute high intensity headache episodes and syncope (nausea) one month ago, left hemiplegics, and no more associated symptoms, was referred to the hospital. The patient had a history of hypertension with drug control and Dengue Hemorrhagic five years ago. Patients that suffer from Dengue Hemorrhagic can eventually have low blood flow with hypo cerebral perfusion which can cause cerebral infarction like “watershed”, which means, stroke in the frontier areas. Most of these lesions occur between the anterior and median cerebral arteries, as well as in the basal ganglia. Since this patient had an old stroke possibly caused by an ischemic event related to Dengue Hemorrhagic five years ago and moreover the patient still lives in the endemic area, it was suspected that the current symptoms could be related to the cerebral hypo perfusion.

 

Diagnosis and comments
CT data acquired with the first SOMATOM Spirit in Brazil shows a lesion detected at right basal ganglia interpreted as encephalic scar from previous event. The current CT Perfusion study shows signals that can be related to hypo perfusion of left basal ganglia.
 


 

Dengue / Dengue Hemorrhagic Fever
Dengue and dengue hemorrhagic fever (DHF) are acute febrile diseases, found in the tropics, with a geographical spread similar to malaria. Caused by Flavivirus, the disease is transmitted to humans by the mosquito Aedes aegypti. The disease is manifested by a sudden onset of fever, with severe headache, joint and muscular pains (myalgias and arthralgias, severe pain gives it the name break-bone fever), leukopenia and rashes. The dengue rash is characteristically bright red and covers most of the body. DHF also shows higher fever, hemorrhagic phenomena, thrombocytopenia, and hemoconcentration. In around 5 percent of cases there is dengue shock syndrome (DDS) and hemorrhage, leading to death. There is no commercially ready vaccine.
 

Examination Protocol

 

Scanner SOMATOM Spirit
Scan area Basal ganglia
Scan length 10 mm
Scan time 40 s
kV 80 kV
Effective mAs 220 mAs
Rotation time 1.5 s
Slice collimation 5.0 mm
Slice width 10 mm
Table feed / rotation 0 mm
Kernel H31s
Contrast 300 mg iodine/ml (Henetix)
Volume 40 ml
Flow rate 5 ml / s
Start delay 5 s
Postprocessing syngo Neuro Perfusion CT

 

La información presentada es solamente para ilustración del lector y no debe usarse como instrucciones para la práctica médica. Cualquier practicante del cuidado de la salud que lea esta información deberá usar su propio conocimiento, capacitación y experiencia en el tratamiento de sus pacientes. Este material no sustituye dicho deber y Siemens Healthineers no lo pone a disposición para ningún propósito al respecto.

Los fármacos y dosis mencionados en el presente son consistentes con la etiqueta de aprobación para usos y/o indicaciones del fármaco. El médico que lo trata es completamente responsable del diagnóstico y tratamiento de los pacientes, incluyendo los medicamentos y dosis prescritas en relación con dicho uso. Las instrucciones de funcionamiento se deben seguir con cuidado cuando se usa el sistema. El origen de los datos técnicos es correspondiente a las fichas técnicas. Los resultados pueden variar.